Christopher Z Lam1, Tanmay Anant Bhamare2, Tamadhir Gazzaz3, David Manson3, Tilman Humpl4, Mike Seed3,2. 1. Department of Diagnostic Imaging, The Hospital for Sick Children, Department of Medical Imaging, University of Toronto, 555 University Ave., M644, Toronto, ON, M5G 1X8, Canada. christopher.lam@sickkids.ca. 2. Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada. 3. Department of Diagnostic Imaging, The Hospital for Sick Children, Department of Medical Imaging, University of Toronto, 555 University Ave., M644, Toronto, ON, M5G 1X8, Canada. 4. Department of Critical Care Medicine, Department of Pediatrics, Division of Cardiology, The Hospital for Sick Children, University of Toronto, Toronto, ON, Canada.
Abstract
BACKGROUND: Secondary pulmonary lymphangiectasia is a complication of congenital heart disease that results from chronic pulmonary venous obstruction. OBJECTIVES: We aimed to evaluate the performance of chest ultrasound (US) in diagnosing secondary pulmonary lymphangiectasia and to review the clinical course of children with secondary pulmonary lymphangiectasia. MATERIALS AND METHODS: Chest US was performed on 26 children with hypoplastic left heart syndrome, total anomalous pulmonary venous connection or cor triatriatum in a prospective observational study. Thirteen children had pulmonary venous obstruction (62% male; median age: 17 days old, range: 1-430 days old) and 13 children did not have obstruction (62% male; median age: 72 days old, range: 4-333 days old). US features of secondary pulmonary lymphangiectasia were documented and diagnostic performance was determined. Clinical course of patients with secondary pulmonary lymphangiectasia was reviewed. RESULTS: Eleven of 13 (84.6%) patients in the obstructed group had a clinical and/or biopsy diagnosis of secondary pulmonary lymphangiectasia. Statistically significant chest US criteria for diagnosis were presence of irregular lung surface (likelihood ratio [LR] 6.8, 95% confidence interval [CI] 1.9-25.1), subpleural cystic appearing structures (LR 3.6, 95% CI 1.2-10.7), and combination of subpleural cystic appearing structures and surface irregularity together (LR 10.9, 95% CI 1.6-75.0). Seven of 11 (63.6%) patients with secondary pulmonary lymphangiectasia died during follow-up, the majority due to cardiopulmonary failure or complications. CONCLUSION: Chest US is an accurate and reproducible bedside method for diagnosing secondary pulmonary lymphangiectasia in patients with pulmonary venous obstruction. These patients may have worse prognoses.
BACKGROUND: Secondary pulmonary lymphangiectasia is a complication of congenital heart disease that results from chronic pulmonary venous obstruction. OBJECTIVES: We aimed to evaluate the performance of chest ultrasound (US) in diagnosing secondary pulmonary lymphangiectasia and to review the clinical course of children with secondary pulmonary lymphangiectasia. MATERIALS AND METHODS: Chest US was performed on 26 children with hypoplastic left heart syndrome, total anomalous pulmonary venous connection or cor triatriatum in a prospective observational study. Thirteen children had pulmonary venous obstruction (62% male; median age: 17 days old, range: 1-430 days old) and 13 children did not have obstruction (62% male; median age: 72 days old, range: 4-333 days old). US features of secondary pulmonary lymphangiectasia were documented and diagnostic performance was determined. Clinical course of patients with secondary pulmonary lymphangiectasia was reviewed. RESULTS: Eleven of 13 (84.6%) patients in the obstructed group had a clinical and/or biopsy diagnosis of secondary pulmonary lymphangiectasia. Statistically significant chest US criteria for diagnosis were presence of irregular lung surface (likelihood ratio [LR] 6.8, 95% confidence interval [CI] 1.9-25.1), subpleural cystic appearing structures (LR 3.6, 95% CI 1.2-10.7), and combination of subpleural cystic appearing structures and surface irregularity together (LR 10.9, 95% CI 1.6-75.0). Seven of 11 (63.6%) patients with secondary pulmonary lymphangiectasia died during follow-up, the majority due to cardiopulmonary failure or complications. CONCLUSION: Chest US is an accurate and reproducible bedside method for diagnosing secondary pulmonary lymphangiectasia in patients with pulmonary venous obstruction. These patients may have worse prognoses.
Authors: David Saul; Karl Degenhardt; Suzanne D Iyoob; Lea F Surrey; Ann M Johnson; Mark P Johnson; Jack Rychik; Teresa Victoria Journal: Pediatr Radiol Date: 2015-12-21
Authors: Anna N Seale; Hideki Uemura; Steven A Webber; John Partridge; Michael Roughton; Siew Y Ho; Karen P McCarthy; Sheila Jones; Lynda Shaughnessy; Jan Sunnegardh; Katarina Hanseus; Hakan Berggren; Sune Johansson; Michael L Rigby; Barry R Keeton; Piers E F Daubeney Journal: Circulation Date: 2010-12-06 Impact factor: 29.690
Authors: J Rychik; A Szwast; S Natarajan; M Quartermain; D D Donaghue; J Combs; J W Gaynor; P J Gruber; T L Spray; M Bebbington; M P Johnson Journal: Ultrasound Obstet Gynecol Date: 2010-10 Impact factor: 7.299
Authors: Christian A Barrera; Teresa Victoria; Fernando A Escobar; Ganesh Krishnamurthy; Christopher L Smith; Julie S Moldenhauer; David M Biko Journal: Pediatr Radiol Date: 2020-11-30
Authors: Karen I Ramirez-Suarez; Luis Octavio Tierradentro-García; David M Biko; Hansel J Otero; Ammie M White; Yoav Dori; Christopher L Smith; Seth Vatsky; Jordan B Rapp Journal: Pediatr Radiol Date: 2022-07-16